Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B: global importance and need for control.

J E Maynard1

  • 1International Task Force on Hepatitis B Immunization, Seattle, WA.

Vaccine
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain.

Vaccine·1999
Same author

The introduction of new vaccines into developing countries.

Vaccine·1999
Same author

Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia.

The Journal of infectious diseases·1995
Same author

Surveillance of hepatitis delta virus infection in Colombia, South America.

Progress in clinical and biological research·1991
Same author

Recovery of hepatitis A virus from a water supply responsible for a common source outbreak of hepatitis A.

American journal of public health·1990
Same author

Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization.

Reviews of infectious diseases·1989
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
Same journal

V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023.

Vaccine·2026
Same journal

In silico selection and in vivo evaluation of scoloptoxin SSD14, Rm-inositol monophosphatase, and Rm-neprilysin as potential anti-tick vaccines.

Vaccine·2026
See all related articles

Hepatitis B (HBV) is a global health threat, causing liver cancer and mortality. Mass infant vaccination via the Expanded Programme on Immunization (EPI) is key to eliminating HBV, with rates potentially dropping 90% in 10 years.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis B virus (HBV) infection affects over 300 million people globally.
  • HBV is a primary cause of liver cancer, contributing to significant mortality worldwide.
  • In high-prevalence areas (10% carrier rate), HBV accounts for 3% of total mortality.

Purpose of the Study:

  • To highlight the global significance of Hepatitis B.
  • To emphasize the role of mass vaccination in HBV elimination strategies.
  • To assess the potential impact of increased vaccine availability and reduced costs.

Main Methods:

  • Review of global HBV prevalence and mortality data.
  • Analysis of vaccination strategies, specifically the Expanded Programme on Immunization (EPI).

Related Experiment Videos

  • Evaluation of trends in hepatitis B vaccine production and pricing.

    • Main Results:

    • Hepatitis B is a leading cause of primary liver cancer and mortality.
    • Mass infant vaccination in areas with >2.5% HBV carrier rates is the only elimination strategy.
    • Increased vaccine production and lower costs offer optimism for a 90% reduction in HBV rates within a decade.

    Conclusions:

    • Hepatitis B vaccination is crucial for global disease control.
    • The Expanded Programme on Immunization (EPI) provides a framework for HBV elimination.
    • Projected reductions in HBV infection rates are substantial due to improved vaccine accessibility.